Accumulate Strides Arcolab on every dip: Ashit Suri

Ashit Suri, Fundamental Research Analyst, JV Capital Services in an interview with ET Now talks about his pick from the pharma stocks.

Orchid Chemicals right now obviously on the back of the news that they are going to be buying out US base Karalex Pharma and also they are looking to actually double their business in 3 years time so in terms of a business outlook for Orchid Chemicals; do you think this particular stock has value in it and probably investor should look at this as one of their options in the pharma space?

To be very honest I am not tracking Orchid Chemicals so I would not really like to comment here. But if one has to look at the pharma space and amongst the smaller players I would suggest Strides Arcolab to be accumulated on every dip and besides that a Jubilant also has turned in very good numbers and reduce its debt expects very positive growth in the coming quarters from the international markets as well as domestically also. So these two would be good accumulate calls Jubilant Organics as well as Strides Arcolab.